clindamycin, Cleocin T, Clinda-Derm (cont.)
Omudhome Ogbru, PharmD
Omudhome Ogbru, PharmD
Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. He was a Professor of Pharmacy Practice and a Regional Clerkship Coordinator for the University of the Pacific School of Pharmacy from 1996-99.
PREPARATIONS: Gel, foam, lotion, solution, swab: 1%
DRUG INTERACTIONS: Clindamycin given orally may act as a neuromuscular blocker. This means it can increase the action of neuromuscular blocking drugs (for example, pancuronium and vecuronium) that block the contraction of muscles. Less clindamycin is absorbed into the blood stream when given topically so the likelihood of this drug interaction is less likely.
PREGNANCY AND BREASTFEEDING SAFETY: The frequency of congenital abnormalities was not increased when pregnant women used clindamycin during the second and third trimesters. Clindamycin has not been properly evaluated during the first trimester of pregnancy. It should only be used during the first trimester of pregnancy if it is clearly needed. Oral clindamycin is excreted in breast milk and either should not be used by nursing mothers or nursing should be stopped. It is not known whether clindamycin given topically is excreted in breast milk.
STORAGE: Clindamycin topical preparations should be stored at room temperature, 20 C to 25 C (68 F to 77 F).
DOSING: A thin film of the lotion, and solution should be applied to affected areas every 12 hours. A thin film of the foam should be applied to the affected areas once daily. The gel may be applied once or twice daily depending on the brand. The swab is used to apply a thin layer of clindamycin film to the affected area twice daily. Each swab should be used once and then discarded.
DRUG CLASS AND MECHANISM:
Medically reviewed by Omudhome Ogbru, PharmD
Reference: FDA Prescribing Information
Medically Reviewed by a Doctor on 1/19/2016
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Back to Medications Index
- Allergic Skin Disorders
- Bacterial Skin Diseases
- Bites and Infestations
- Diseases of Pigment
- Fungal Skin Diseases
- Medical Anatomy and Illustrations
- Noncancerous, Precancerous & Cancerous Tumors
- Oral Health Conditions
- Papules, Scales, Plaques and Eruptions
- Scalp, Hair and Nails
- Sexually Transmitted Diseases (STDs)
- Vascular, Lymphatic and Systemic Conditions
- Viral Skin Diseases
- Additional Skin Conditions